Skip to main content
Clinical Trials/NCT02944643
NCT02944643CompletedNot Applicable

Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis

Hunter Holmes Mcguire Veteran Affairs Medical Center1 site in 1 country20 target enrollmentStarted: June 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Beck Depression Inventory (patients)

Study Overview

Brief Summary

Chronic liver disease and cirrhosis pose a huge financial burden to the health care system. This includes the cost of medical care, employment, disability-related issues and reduced survival. Specifically, the complication of cirrhosis known as hepatic encephalopathy (HE) especially hinders quality of life, the performance of activities of daily living and the ability to drive a motor vehicle in affected subjects. The hidden burden to family members and caregivers of these subjects, however, has been all but ignored to date. Evaluation of family members and caregivers is essential. The burden of caring for someone with liver disease can result in added cost for health care for family members and caregivers and is typically not recognized. The importance of the burden to families and family members or caregivers resulting from other neurological diseases such as Alzheimer's has been well evaluated and specific strategies to educate and counsel family members and caregivers have been elaborated. This is important because as the findings of this study have emerged, we have found that both Veterans and non-Veterans with cirrhosis and HE have a poor quality of life, worse socio-economic status and place a significantly higher burden on their family members or caregivers than those without HE

Detailed Description

The initial intake visit will include an overall assessment of the situation with the subject and family members or caregivers by the study physician and description of the group therapy. If the subjects and family members or caregivers want to continue, they will be asked to visit with the psychologist individually (subject first, then family member or caregiver, then both) in order to confirm their insight into the disease process and assess their readiness and appropriateness for the group therapy.

All concerns regarding confidentiality and details to be discussed during the group therapy sessions will be reiterated to subjects and family members or caregivers individually. They can then choose to participate or not. If they choose not to participate, they will be seen in 1- 3 months to complete the all tests / questionnaires detailed as in the measurements section

Subjects and family members or caregivers agreeing to participate in group therapy will be required to attend four weekly group therapy sessions in order for them to be considered as group therapy recipients. If they choose to terminate the group at any time, they will be free to do so and will be asked to complete all tests / questionnaires detailed as in the measurements section

GROUP INTERVENTION FORMAT:

Group therapy sessions will be conducted on a weekly basis over a four week period. The group therapy sessions will last approximately one hour. The group will not have a rolling admission meaning members will be required to attend all scheduled group sessions.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Inclusion Criteria:
  • •Cirrhosis proven by radiology, endoscopy (esophageal varices present) or biopsy
  • •Able to give informed consent as determined by the study staff
  • •Have a family member or caregiver who lives with them that is willing to participate

Exclusion Criteria

  • •Unable to give consent
  • •Active psychosis
  • •Acute suicidal ideation
  • •No identified family member or caregiver
  • •Caregivers/Family members:
  • •Inclusion Criteria:
  • •Sharing living space with cirrhotic patient for at least 3 years
  • •Able and willing to participate in the groups
  • •Exclusion Criteria:
  • •Unfamiliar with patient's routines and does not live in the same space
  • •Unwilling to consent or participate

Arms & Interventions

Active group

Experimental

Will get the mindfulness and support groups

Intervention: Mindfulness and Support Groups (Other)

Outcomes

Primary Outcomes

Beck Depression Inventory (patients)

Time Frame: 4 weeks

Secondary Outcomes

  • Epworth Sleepiness Scale (patients)(4 weeks)
  • Beck Anxiety Inventory (patients)(4 weeks)
  • Zarit Burden Interview (caregivers only)(4 weeks)
  • Sickness Impact Profile (patients)(4 weeks)
  • Pittsburgh Sleep Quality Index (patients)(4 weeks)

Investigators

Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Jasmohan Bajaj

Associate Professor, GI Section

Hunter Holmes Mcguire Veteran Affairs Medical Center

Study Sites (1)

Loading locations...

Similar Trials